BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 32377290)

  • 1. Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway.
    Hassanein EHM; Sayed AM; Hussein OE; Mahmoud AM
    Oxid Med Cell Longev; 2020; 2020():1675957. PubMed ID: 32377290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones.
    de Freitas Silva M; Pruccoli L; Morroni F; Sita G; Seghetti F; Viegas C; Tarozzi A
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30037040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Coumarin Derivatives Activating Nrf2 Signaling Pathway as Lead Compounds for the Design and Synthesis of Intestinal Anti-Inflammatory Drugs.
    Di Stasi LC
    Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
    Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
    J Virol; 2020 May; 94(10):. PubMed ID: 32161178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
    Lu MC; Ji JA; Jiang ZY; You QD
    Med Res Rev; 2016 Sep; 36(5):924-63. PubMed ID: 27192495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
    Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
    Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation.
    Lu MC; Zhao J; Liu YT; Liu T; Tao MM; You QD; Jiang ZY
    Redox Biol; 2019 Sep; 26():101266. PubMed ID: 31279986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
    Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
    Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis.
    Li AL; Shen T; Wang T; Zhou MX; Wang B; Song JT; Zhang PL; Wang XL; Ren DM; Lou HX; Wang XN
    Free Radic Biol Med; 2019 Sep; 141():21-33. PubMed ID: 31167117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1.
    Arora R; Sawney S; Saini V; Steffi C; Tiwari M; Saluja D
    Mol Cancer; 2016 Oct; 15(1):64. PubMed ID: 27756327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (-)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia.
    Chiou YS; Huang Q; Ho CT; Wang YJ; Pan MH
    Free Radic Biol Med; 2016 May; 94():1-16. PubMed ID: 26878775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy.
    Adelusi TI; Du L; Hao M; Zhou X; Xuan Q; Apu C; Sun Y; Lu Q; Yin X
    Biomed Pharmacother; 2020 Mar; 123():109732. PubMed ID: 31945695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions.
    Lu MC; Shao HL; Liu T; You QD; Jiang ZY
    Eur J Med Chem; 2020 Dec; 207():112734. PubMed ID: 32866756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses.
    Perez-Leal O; Barrero CA; Merali S
    J Biol Chem; 2017 Aug; 292(34):14108-14121. PubMed ID: 28684421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharide from Ostrea rivularis attenuates reproductive oxidative stress damage via activating Keap1-Nrf2/ARE pathway.
    Li S; Song Z; Liu T; Liang J; Yuan J; Xu Z; Sun Z; Lai X; Xiong Q; Zhang D
    Carbohydr Polym; 2018 Apr; 186():321-331. PubMed ID: 29455993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of pyrroloquinoline quinine against oxidative stress-induced cellular senescence and inflammation in human renal tubular epithelial cells via Keap1/Nrf2 signaling pathway.
    Wang Z; Han N; Zhao K; Li Y; Chi Y; Wang B
    Int Immunopharmacol; 2019 Jul; 72():445-453. PubMed ID: 31035086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate potentially abrogates fluoride induced lung oxidative stress, inflammation via Nrf2/Keap1 signaling pathway in rats: An in-vivo and in-silico study.
    Shanmugam T; Selvaraj M; Poomalai S
    Int Immunopharmacol; 2016 Oct; 39():128-139. PubMed ID: 27472294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
    Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
    Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
    Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urolithin B, a gut microbiota metabolite, protects against myocardial ischemia/reperfusion injury via p62/Keap1/Nrf2 signaling pathway.
    Zheng D; Liu Z; Zhou Y; Hou N; Yan W; Qin Y; Ye Q; Cheng X; Xiao Q; Bao Y; Luo J; Wu X
    Pharmacol Res; 2020 Mar; 153():104655. PubMed ID: 31996327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.